1.
Carpagnano GE, Scioscia G, Buonamico E, Lacedonia D, Diaferia F, Capozza E, et al. Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management. Multidiscip Respir Med [Internet]. 2022 Feb. 4 [cited 2025 Jun. 30];17. Available from: https://mail.mrmjournal.org/index.php/mrm/article/view/797